PHARMACY

Watson gets green light for generic Yaz

BY Allison Cerra

PARSIPPANY, N.J. — Watson Pharmaceuticals subsidiary Watson Labs has received regulatory approval for a generic oral contraceptive.

Watson Labs said its abbreviated new drug application for Vestura (3-mg drospirenone and 0.02-mg ethinyl estradiol) was approved by the Food and Drug Administration.

Watson currently is involved in patent litigation with Bayer concerning the product, which is a generic version of Bayer’s Yaz oral contraceptive product.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

MedPro Rx president Nancy McFarlane wins Stevie Award

BY Alaric DeArment

RALEIGH, N.C. — MedPro Rx president Nancy McFarlane won a Stevie Award for Best Entrepreneur, the specialty pharmacy provider said.

McFarlane won the award for the category of service businesses with up to 100 employers in the Stevie Awards for Women in Business, having led the company to multimillion-dollar sales over the past nine years, the company said. McFarlane founded the company in 2002.

The Stevie Awards for Women in Business recognizes women executives, entrepreneurs and the companies they run around the world. More than 1,300 entries were submitted this year for consideration in 75 categories.

The latest award adds to the list of recognitions the company has racked up over the last couple of months. Earlier this month, the Triangle Business Journal included MedPro in its list of the 50 fastest-growing companies in the North Carolina Research Triangle for the fourth year in a row. Last month, Business Leader Magazine gave McFarlane its 2011 Movers & Shakers Award.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Berwick steps down from post as CMS administrator

BY Allison Cerra

WASHINGTON — The Obama administration confirmed last week that Centers for Medicare and Medicaid Services administrator Donald Berwick will step down from his post on Dec. 2.

Berwick, who was nominated to the position by President Obama in April 2010, was supposed to lead the agency through the end of the year as part of his recess appointment.

Marilyn Tavenner, CMS principal deputy administrator, will succeed Berwick, according to a statement made by Health and Human Services secretary Kathleen Sebelius.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?